Descovy is a medication used to treat HIV. It is also prescribed as PrEP (preexposure prophylaxis) to prevent HIV infection in individuals who are at risk of HIV. When used as HIV treatment, Descovy ...
Descovy (emtricitabine/tenofovir alafenamide) is a brand-name prescription drug that’s used to help prevent HIV. It’s not available as a generic drug. Descovy comes as an oral tablet. The active ...
One big task for Gilead Sciences’ HIV franchise in the coming year is to save some $2.5 billion in annual sales by switching as many PrEP patients as possible from Truvada to newly approved Descovy ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Gilead Sciences Canada, Inc. (Gilead Canada) today announced that Health Canada has granted a Notice of Compliance (NOC) for DESCOVY® (emtricitabine 200 mg and ...
Q3 2025 Management View Daniel O'Day, Chairman & CEO, stated that "our third quarter earnings underscore the growing momentum you're seeing from Gilead today, which is driven by our strong portfolio ...
You may have heard about Descovy (des-ko'-vee), a medicine approved by the FDA in 2015. Descovy is approved to treat HIV. It can also help prevent people from getting HIV through sex. People with HIV ...
As expected, Gilead’s Descovy had no problem securing backing from an FDA panel of experts for HIV prevention in men and transgender women. But beyond that, it ran into some issues. On Wednesday, an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback